Effect of carnitine supplementation on mental and physical well being of patients on haemodialysis for end stage kidney disease
Not Applicable
Not yet recruiting
- Conditions
- End stage renal diseaseRenal and Urogenital - Kidney disease
- Registration Number
- ACTRN12624000504516
- Lead Sponsor
- Dr. Obaid Ur Rehman, Pak Emirates Military Hospital Rawalpindi Pakistan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
(1)Patients diagnosed with end-stage renal disease undergoing maintenance haemodialysis two times a week for at least 3 months.
(2)Patients willing to participate and provide informed consent.
Exclusion Criteria
(1) Patients with a history of allergic reactions to levocarnitine.
(2) Patients who have received L-carnitine therapy in previous 3 months.
(3) Patients with cognitive difficulties who are unable to comprehend questions on the SF-36 questionnaire
(4) Limited mobility
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method